Monte Rosa Therapeutics Inc (GLUE)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
1,004,139,000
EV to revenue ratio (TTM)
14.98
EV to ebitda
9.52
Financial Performance
Revenue (TTM)
28,727,000
Gross profit (TTM)
-133,632,000
EBITDA
-173,728,000
Profitability
Operating margin (TTM)
-548.00%
Profit margin
0.00%
Return on assets (TTM)
-21.60%
Return on equity (TTM)
-42.70%
Per Share Metrics
Revenue per share (TTM)
0.31
EPS
-1.75
Diluted EPS (TTM)
-1.75
Book value
5.72
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
10.02
PEG ratio
Price to sales ratio (TTM)
34.95
Price to book ratio (TTM)
2.08
Growth
Quarterly earnings growth (YoY)
-61.30%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
2
Buy
6
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.5